Application

·It is suitable for the evaluation of the killing function of immune cell products such as NK cells, CAR-NK cells, CAR-T cells, TCR-T cells, Tm cells, etc. on different tumour cell lines (suspended target cells).

·CMC and quality research phase: In the early development phase of cell therapy products, the cytotoxic effect is evaluated and the process is optimised.

·Release testing, stability and comparability studies phase: During the mid-term process lock phase of cell therapy products, a cell killing method for the product is established, and release testing and stability testing of the cell product are performed.

Performance Index

Data Sharing

FACS analysis of the killing rate of NK cells against CFSE-labeled K562 target cells

Cell Cytotoxicity curves of NK cells against CFSE-labelled K562 target cells